2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome

The Writing Group of 2018 Taiwan Guidelines for the Management of Non ST-segment Elevation Acute Coronary Syndrome

Research output: Contribution to journalArticle

9 Citations (Scopus)


In Taiwan, the incidence of non-ST segment elevation acute coronary syndrome (NSTE-ACS) continues to increase in recent years. The purpose of this guideline is to help health care professionals in Taiwan to use adequate tests and treatments for management of NSTE-ACS. For rapid diagnosis, in addition to history and physical examination, 0/3 h rapid diagnosis protocol with high sensitivity cardiac troponin assay is recommended in this guideline. Dual antiplatelet and anticoagulation therapies are important parts in the initial treatment. Risk stratification should be performed to identify high risk patients for early coronary angiography. Through evaluation of the coronary anatomy and other clinical factors, the decision for coronary revascularization, either by percutaneous coronary intervention or coronary artery bypass grafting, should be decided by the heart team. The duration of dual antiplatelet therapy should be given for at least 12 months after discharge. Other secondary preventive medications are also recommended for long term use.

Original languageEnglish
Pages (from-to)766-790
Number of pages25
JournalJournal of the Formosan Medical Association
Issue number9
Publication statusPublished - Sep 1 2018



  • Acute coronary syndrome
  • Guideline
  • Taiwan

ASJC Scopus subject areas

  • Medicine(all)

Cite this